# Rockwell Automation, Inc: financial statements, quarterly

ROK · NYSE · CIK 1024478 · [Technology](/sectors/technology.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/rok.md) · [Financials](/companies/rok/financials.md) · [Filings](/companies/rok/filings.md) · [Insiders](/companies/rok/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rok/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,563 d](/filings/0001024478-25-000116.md) | [2,052](/filings/0001024478-25-000010.md) | [2,126](/filings/0001024478-25-000035.md) | [2,051](/filings/0001024478-25-000083.md) | [2,035 d](/filings/0001024478-25-000116.md) | [1,881](/filings/0001024478-26-000005.md) | [2,001](/filings/0001024478-26-000022.md) | [2,144](/filings/0001024478-26-000030.md) | [2,316 d](/filings/0001024478-25-000116.md) | [2,105](/filings/0001024478-26-000005.md) | [2,239](/filings/0001024478-26-000022.md) | [2,313](/filings/0001024478-26-000030.md) |
| Cost of revenue | $m | [801 d](/filings/0001024478-25-000116.md) | [1,257](/filings/0001024478-25-000010.md) | [1,293](/filings/0001024478-25-000035.md) | [1,256](/filings/0001024478-25-000083.md) | [607 d](/filings/0001024478-25-000116.md) | [1,003](/filings/0001024478-26-000005.md) | [1,029](/filings/0001024478-26-000022.md) | [1,098](/filings/0001024478-26-000030.md) | [1,196 d](/filings/0001024478-25-000116.md) | [1,089](/filings/0001024478-26-000005.md) | [1,114](/filings/0001024478-26-000022.md) | [1,169](/filings/0001024478-26-000030.md) |
| Gross profit | $m | [1,762 d](/filings/0001024478-25-000116.md) | [795](/filings/0001024478-25-000010.md) | [833](/filings/0001024478-25-000035.md) | [795](/filings/0001024478-25-000083.md) | [1,428 d](/filings/0001024478-25-000116.md) | [878](/filings/0001024478-26-000005.md) | [972](/filings/0001024478-26-000022.md) | [1,046](/filings/0001024478-26-000030.md) | [1,120 d](/filings/0001024478-25-000116.md) | [1,016](/filings/0001024478-26-000005.md) | [1,125](/filings/0001024478-26-000022.md) | [1,144](/filings/0001024478-26-000030.md) |
| Research and development | $m | not reported | not reported | not reported | not reported | not reported | [156](/filings/0001024478-26-000005.md) | [162](/filings/0001024478-26-000022.md) | [170](/filings/0001024478-26-000030.md) | [191 d](/filings/0001024478-25-000116.md) | [172](/filings/0001024478-26-000005.md) | [180](/filings/0001024478-26-000022.md) | [173](/filings/0001024478-26-000030.md) |
| Selling, general and administrative | $m | [552 d](/filings/0001024478-25-000116.md) | [514](/filings/0001024478-25-000010.md) | [501](/filings/0001024478-25-000035.md) | [501](/filings/0001024478-25-000083.md) | [485 d](/filings/0001024478-25-000116.md) | [476](/filings/0001024478-26-000005.md) | [469](/filings/0001024478-26-000022.md) | [498](/filings/0001024478-26-000030.md) | [471 d](/filings/0001024478-25-000116.md) | [478](/filings/0001024478-26-000005.md) | [478](/filings/0001024478-26-000022.md) | [490](/filings/0001024478-26-000030.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | [321](/filings/0001024478-26-000005.md) | [408](/filings/0001024478-26-000022.md) | [454](/filings/0001024478-26-000030.md) | [520 d](/filings/0001024478-25-000116.md) | [435](/filings/0001024478-26-000005.md) | [530](/filings/0001024478-26-000022.md) | [550](/filings/0001024478-26-000030.md) |
| Interest expense | $m | [31.0 d](/filings/0001024478-23-000126.md) | [33.3](/filings/0001024478-24-000008.md) | [39.2](/filings/0001024478-24-000052.md) | [41.0](/filings/0001024478-25-000083.md) | [40.0 d](/filings/0001024478-25-000116.md) | [39.0](/filings/0001024478-26-000005.md) | [39.0](/filings/0001024478-26-000022.md) | [41.0](/filings/0001024478-26-000030.md) | [37.0 d](/filings/0001024478-25-000116.md) | [32.0](/filings/0001024478-26-000005.md) | [36.0](/filings/0001024478-26-000022.md) | [33.0](/filings/0001024478-26-000030.md) |
| Income tax | $m | [111 d](/filings/0001024478-25-000116.md) | [47.0](/filings/0001024478-25-000010.md) | [45.0](/filings/0001024478-25-000035.md) | [24.0](/filings/0001024478-25-000083.md) | [36.0 d](/filings/0001024478-25-000116.md) | [35.0](/filings/0001024478-26-000005.md) | [51.0](/filings/0001024478-26-000022.md) | [49.0](/filings/0001024478-26-000030.md) | [33.0 d](/filings/0001024478-25-000116.md) | [40.0](/filings/0001024478-26-000005.md) | [89.0](/filings/0001024478-26-000022.md) | [62.0](/filings/0001024478-26-000030.md) |
| Net income | $m | [303 d](/filings/0001024478-25-000116.md) | [215](/filings/0001024478-25-000010.md) | [266](/filings/0001024478-25-000035.md) | [232](/filings/0001024478-25-000083.md) | [240 d](/filings/0001024478-25-000116.md) | [184](/filings/0001024478-26-000005.md) | [252](/filings/0001024478-26-000022.md) | [295](/filings/0001024478-26-000030.md) | [138 d](/filings/0001024478-25-000116.md) | [305](/filings/0001024478-26-000005.md) | [350](/filings/0001024478-26-000022.md) | [408](/filings/0001024478-26-000030.md) |
| Diluted EPS | $ per share | not reported | [1.86](/filings/0001024478-25-000010.md) | [2.31](/filings/0001024478-25-000035.md) | [2.02](/filings/0001024478-25-000083.md) | not reported | [1.61](/filings/0001024478-26-000005.md) | [2.22](/filings/0001024478-26-000022.md) | [2.60](/filings/0001024478-26-000030.md) | not reported | [2.69](/filings/0001024478-26-000005.md) | [3.10](/filings/0001024478-26-000022.md) | [3.65](/filings/0001024478-26-000030.md) |
| Basic EPS | $ per share | not reported | [1.87](/filings/0001024478-25-000010.md) | [2.32](/filings/0001024478-25-000035.md) | [2.03](/filings/0001024478-25-000083.md) | not reported | [1.62](/filings/0001024478-26-000005.md) | [2.22](/filings/0001024478-26-000022.md) | [2.61](/filings/0001024478-26-000030.md) | not reported | [2.71](/filings/0001024478-26-000005.md) | [3.11](/filings/0001024478-26-000022.md) | [3.66](/filings/0001024478-26-000030.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.1](/filings/0001024478-25-000116.md) | [0.4](/filings/0001024478-24-000008.md) | [0.5](/filings/0001024478-24-000052.md) | [0.4](/filings/0001024478-24-000088.md) | [0.5](/filings/0001024478-25-000116.md) | [0.5](/filings/0001024478-25-000010.md) | [0.5](/filings/0001024478-25-000035.md) | [0.5](/filings/0001024478-25-000083.md) | [0.5](/filings/0001024478-26-000030.md) | [0.4](/filings/0001024478-26-000005.md) | [0.4](/filings/0001024478-26-000022.md) | [0.5](/filings/0001024478-26-000030.md) |
| Current assets | $bn | [4.9](/filings/0001024478-24-000107.md) | [4.1](/filings/0001024478-24-000008.md) | [4.1](/filings/0001024478-24-000052.md) | [3.9](/filings/0001024478-24-000088.md) | [3.9](/filings/0001024478-25-000116.md) | [3.7](/filings/0001024478-25-000010.md) | [3.8](/filings/0001024478-25-000035.md) | [3.9](/filings/0001024478-25-000083.md) | [3.9](/filings/0001024478-26-000030.md) | [4.0](/filings/0001024478-26-000005.md) | [4.1](/filings/0001024478-26-000022.md) | [3.9](/filings/0001024478-26-000030.md) |
| Total assets | $bn | [11.3](/filings/0001024478-25-000116.md) | [11.3](/filings/0001024478-24-000008.md) | [11.4](/filings/0001024478-24-000052.md) | [11.2](/filings/0001024478-24-000088.md) | [11.2](/filings/0001024478-25-000116.md) | [10.9](/filings/0001024478-25-000010.md) | [11.0](/filings/0001024478-25-000035.md) | [11.2](/filings/0001024478-25-000083.md) | [11.2](/filings/0001024478-26-000030.md) | [11.2](/filings/0001024478-26-000005.md) | [11.3](/filings/0001024478-26-000022.md) | [11.1](/filings/0001024478-26-000030.md) |
| Current liabilities | $bn | [3.4](/filings/0001024478-24-000107.md) | [3.3](/filings/0001024478-24-000008.md) | [3.7](/filings/0001024478-24-000052.md) | [3.8](/filings/0001024478-24-000088.md) | [3.6](/filings/0001024478-25-000116.md) | [3.5](/filings/0001024478-25-000010.md) | [3.6](/filings/0001024478-25-000035.md) | [3.7](/filings/0001024478-25-000083.md) | [3.4](/filings/0001024478-26-000030.md) | [3.5](/filings/0001024478-26-000005.md) | [3.7](/filings/0001024478-26-000022.md) | [3.7](/filings/0001024478-26-000030.md) |
| Long-term debt | $bn | [2.9](/filings/0001024478-24-000088.md) | [2.9](/filings/0001024478-24-000008.md) | [2.6](/filings/0001024478-24-000052.md) | [2.6](/filings/0001024478-24-000088.md) | [2.6](/filings/0001024478-25-000116.md) | [2.6](/filings/0001024478-25-000010.md) | [2.6](/filings/0001024478-25-000035.md) | [2.6](/filings/0001024478-25-000083.md) | [2.6](/filings/0001024478-26-000030.md) | [2.6](/filings/0001024478-26-000005.md) | [2.6](/filings/0001024478-26-000022.md) | [2.6](/filings/0001024478-26-000030.md) |
| Current portion of debt | $bn | [0.0](/filings/0001024478-24-000107.md) | [0.0](/filings/0001024478-24-000008.md) | [0.3](/filings/0001024478-24-000052.md) | [0.3](/filings/0001024478-24-000088.md) | [0.3](/filings/0001024478-25-000116.md) | [0.3](/filings/0001024478-25-000010.md) | [0.0](/filings/0001024478-25-000035.md) | [0.0](/filings/0001024478-25-000083.md) | [0.0](/filings/0001024478-26-000030.md) | [0.1](/filings/0001024478-26-000005.md) | [0.0](/filings/0001024478-26-000022.md) | [0.0](/filings/0001024478-26-000030.md) |
| Short-term borrowings | $bn | [0.1](/filings/0001024478-24-000107.md) | [0.5](/filings/0001024478-24-000008.md) | [0.8](/filings/0001024478-24-000052.md) | [0.8](/filings/0001024478-24-000088.md) | [0.8](/filings/0001024478-25-000116.md) | [0.7](/filings/0001024478-25-000010.md) | [1.1](/filings/0001024478-25-000035.md) | [0.8](/filings/0001024478-25-000083.md) | [0.6](/filings/0001024478-26-000030.md) | [0.8](/filings/0001024478-26-000005.md) | [1.1](/filings/0001024478-26-000022.md) | [0.7](/filings/0001024478-26-000030.md) |
| Shareholders' equity | $bn | [3.6](/filings/0001024478-24-000107.md) | [3.6](/filings/0001024478-24-000008.md) | [3.5](/filings/0001024478-24-000052.md) | [3.3](/filings/0001024478-24-000088.md) | [3.5](/filings/0001024478-25-000116.md) | [3.4](/filings/0001024478-25-000010.md) | [3.4](/filings/0001024478-25-000035.md) | [3.5](/filings/0001024478-25-000083.md) | [3.7](/filings/0001024478-26-000030.md) | [3.7](/filings/0001024478-26-000005.md) | [3.5](/filings/0001024478-26-000022.md) | [3.5](/filings/0001024478-26-000030.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [839 d](/filings/0001024478-25-000116.md) | [33.0](/filings/0001024478-25-000010.md) | [120 d](/filings/0001024478-25-000035.md) | [279 d](/filings/0001024478-25-000083.md) | [432 d](/filings/0001024478-25-000116.md) | [364](/filings/0001024478-26-000005.md) | [199 d](/filings/0001024478-26-000022.md) | [527 d](/filings/0001024478-26-000030.md) | [454 d](/filings/0001024478-25-000116.md) | [234](/filings/0001024478-26-000005.md) | [320 d](/filings/0001024478-26-000022.md) | [724 d](/filings/0001024478-26-000030.md) |
| Capital expenditure | $m | [63.2 d](/filings/0001024478-23-000126.md) | [68.0](/filings/0001024478-25-000010.md) | [51.0 d](/filings/0001024478-25-000035.md) | [41.0 d](/filings/0001024478-25-000083.md) | [65.0 d](/filings/0001024478-25-000116.md) | [71.0](/filings/0001024478-26-000005.md) | [28.0 d](/filings/0001024478-26-000022.md) | [38.0 d](/filings/0001024478-26-000030.md) | [49.0 d](/filings/0001024478-25-000116.md) | [64.0](/filings/0001024478-26-000005.md) | [45.0 d](/filings/0001024478-26-000022.md) | [70.0 d](/filings/0001024478-26-000030.md) |
| Dividends paid | $m | [135 d](/filings/0001024478-25-000116.md) | [144](/filings/0001024478-25-000010.md) | [143 d](/filings/0001024478-25-000035.md) | [142 d](/filings/0001024478-25-000083.md) | [142 d](/filings/0001024478-25-000116.md) | [149](/filings/0001024478-26-000005.md) | [148 d](/filings/0001024478-26-000022.md) | [147 d](/filings/0001024478-26-000030.md) | [147 d](/filings/0001024478-25-000116.md) | [156](/filings/0001024478-26-000005.md) | [153 d](/filings/0001024478-26-000022.md) | [155 d](/filings/0001024478-26-000030.md) |
| Share repurchases | $m | [54.9 d](/filings/0001024478-25-000116.md) | [120](/filings/0001024478-25-000010.md) | [194 d](/filings/0001024478-25-000035.md) | [163 d](/filings/0001024478-25-000083.md) | [118 d](/filings/0001024478-25-000116.md) | [100](/filings/0001024478-26-000005.md) | [132 d](/filings/0001024478-26-000022.md) | [124 d](/filings/0001024478-26-000030.md) | [69.0 d](/filings/0001024478-25-000116.md) | [153](/filings/0001024478-26-000005.md) | [446 d](/filings/0001024478-26-000022.md) | [155 d](/filings/0001024478-26-000030.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment, us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-12-31) | Q2 FY2023 (2023-03-31) | Q3 FY2023 (2023-06-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [116](/filings/0001024478-24-000008.md) | [116](/filings/0001024478-24-000052.md) | [116](/filings/0001024478-24-000088.md) | [115](/filings/0001024478-25-000010.md) | [115](/filings/0001024478-25-000035.md) | [114](/filings/0001024478-25-000083.md) | [114](/filings/0001024478-26-000005.md) | [113](/filings/0001024478-26-000022.md) | [113](/filings/0001024478-26-000030.md) | [113](/filings/0001024478-26-000005.md) | [113](/filings/0001024478-26-000022.md) | [112](/filings/0001024478-26-000030.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 111,048,676 at 2026-06-30, from the cover of the [10-Q filed 2026-08-04](/filings/0001024478-26-000030.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.